Currently, we are looking for a new Technologist/Senior Technologist, who has experience with cell-based assays to join our molecular pharmacology team. If this sounds like you, and you are ready to take on a broad area of responsibilities with an independent attitude, you are a match for us.
The molecular pharmacology department is responsible for generating the in vitro data to select and characterize our clinical candidates across all projects. We use molecular biology and peptide display methodologies to support the identification of potential drug candidates and employ a broad range of biochemical and cell-based assays to optimize and guide the development of our molecules towards the clinic. The department consists of 10 scientists and 7 technicians. You may not know all the methods we use from the start so there will be a good opportunity to learn more.
Responsibilities
- Development and optimization of new protocols & assays with other members of the department
- Testing of new peptide drug candidates in in vitro assays
- Planning and execution of the practical work
- Processing instrument data in specialized software and databases
- Documentation of laboratory work in our electronic laboratory notebook
- In addition, responsibilities for maintenance of lab and lab equipment.
- Good collaboration both within and cross departmental to ensure pace, quality, and exchange of experimental methods and ideas.
Candidate profile
The successful candidate will have most or all of the below qualifications:
- Education as technologist/technician with at least 3 years of experience with laboratory work.
- Hands-on experience with cultivation of mammalian cells.
- Experience with cell-based assays, such as intracellular signaling assays
- Interest in acquiring new skills and learning new methods.
- Good documentation skills
- Good understanding of written and spoken English (company language)
- If you also have experience in areas like lab-automation, molecular biology, flow cytometry, ex vivo experiments, biomarker measurements, or protein expression it is a plus, but not required.
Bonding to innovate
Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.
We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise.
We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.
The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.
Let’s bond and be bold
We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities
To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/
Interested? Please apply no later than September 27, 2024, or as soon as possible. The applications will be reviewed as they come in.
For further information, please contact Head of Department Jacob Fog at JFog@zealandpharma.com
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.
